New insights regarding HCV-NS5A structure/function and indication of genotypic differences

Virology Journal

Volumn 9, Issue , 2012, Pages

  Yamasaki, Lilian H T ^a,d   Arcuri, Helen A ^b   Jardim, Ana Carolina G ^a   Bittar, Cintia ^a   De Carvalho Mello, Isabel Maria V G ^c   Rahal, Paula ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d Laboratorio de Estudos Genomicos   (Brazil)

Author keywords

Bioinformatics; Genotype; Hepatitis C virus; IFN response; Non structural 5A protein; Quasispecies

Indexed keywords

INTEGRIN; NONSTRUCTURAL PROTEIN 5A; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID COMPOSITION; ARTICLE; CELL FUNCTION; COMPUTER MODEL; ENZYME ACTIVITY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; MYRISTYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; CONFORMATION; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS C; HUMAN; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; VIROLOGY;

HEPATITIS C VIRUS;

HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84855601913     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-14     Document Type: Article

References (62)

1. Evasion of intracellular host defence by hepatitis C virus. Gale M Jr, Foy EM, Nature 2005 436 939 945 10.1038/nature04078 16107833 (Pubitemid 41191669)
2. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R, PLoS Pathog 2008 4 1000035 10.1371/journal.ppat.1000035 18369481 (Pubitemid 351631086)
3. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G, N Engl J Med 1989 321 1494 1500 10.1056/NEJM198911303212202 2509915 (Pubitemid 20015539)
4. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al. Proc Natl Acad Sci USA 1990 87 6547 6549 10.1073/pnas.87.17.6547 2168552
5. Genetic diversity and evolution of hepatitis C virus-15 years on. Simmonds P, J Gen Virol 2004 85 3173 3188 10.1099/vir.0.80401-0 15483230 (Pubitemid 39445434)
6. Nomenclature and numbering of the hepatitis C virus. Kuiken C, Simmonds P, Methods Mol Biol 2009 510 33 53 10.1007/978-1-59745-394-3-4 19009252
7. Hepatitis C: an update. Moradpour D, Cerny A, Heim MH, Blum HE, Swiss Med Wkly 2001 131 291 298 11584690 (Pubitemid 32601558)
8. The epidemic behavior of the hepatitis C virus. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH, Science 2001 292 2323 2325 10.1126/science.1058321 11423661 (Pubitemid 32568053)
9. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS, Science 1998 282 103 107 9756471 (Pubitemid 28471138)
10. A primer on the molecular virology of hepatitis C. Moradpour D, Blum HE, Liver Int 2004 24 519 525 10.1111/j.1478-3231.2004.0965.x 15566499 (Pubitemid 40028601)
11. Molecular biology and clinical implication of hepatitis C virus. Lyra AC, Fan X, Di Bisceglie AM, Braz J Med Biol Res 2004 37 691 695 10.1590/S0100-879X2004000500010 15107931 (Pubitemid 38702312)
12. Hepatitis E virus and neurologic disorders. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR, Emerg Infect Dis 2011 17 173 179 21291585
13. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. Reed KE, Xu J, Rice CM, J Virol 1997 71 7187 7197 9311791 (Pubitemid 27391652)
14. Hepatitis C virus NS5A: tales of a promiscuous protein. Macdonald A, Harris M, J Gen Virol 2004 85 2485 2502 10.1099/vir.0.80204-0 15302943 (Pubitemid 39214345)
15. Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. Liang Y, Ye H, Kang CB, Yoon HS, Biochemistry 2007 46 11550 11558 10.1021/bi700776e 17880107 (Pubitemid 47585500)
16. Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. Love RA, Brodsky O, Hickey MJ, Wells PA, Cronin CN, J Virol 2009 83 4395 4403 10.1128/JVI.02352-08 19244328
17. The NS5A protein of hepatitis C virus is a zinc metalloprotein. Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM, J Biol Chem 2004 279 48576 48587 10.1074/jbc.M407787200 15339921 (Pubitemid 39625732)
18. Function follows form: the structure of the N-terminal domain of HCV NS5A. Moradpour D, Brass V, Penin F, Hepatology 2005 42 732 735 10.1002/hep.20851 16116650 (Pubitemid 41233668)
19. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, Penin F, Moradpour D, J Biol Chem 2002 277 8130 8139 10.1074/jbc.M111289200 11744739 (Pubitemid 34968267)
20. Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. Liu S, Ansari IH, Das SC, Pattnaik AK, J Gen Virol 2006 87 323 327 10.1099/vir.0.81407-0 16432018 (Pubitemid 43169258)
21. Domain 3 of NS5A protein from the hepatitis C virus has intrinsic {alpha}-helical propensity and is a substrate of Cyclophilin A. Verdegem D, Badillo A, Wieruszeski JM, Landrieu I, Leroy A, Bartenschlager R, Penin F, Lippens G, Hanoulle X, J Biol Chem 2011
22. Viral determinants of resistance to treatment in patients with hepatitis C. Wohnsland A, Hofmann WP, Sarrazin C, Clin Microbiol Rev 2007 20 23 38 10.1128/CMR.00010-06 17223621 (Pubitemid 46167766)
23. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. Neumann AU, Lam NP, Dahari H, Davidian M, Wiley TE, Mika BP, Perelson AS, Layden TJ, J Infect Dis 2000 182 28 35 10.1086/315661 10882578 (Pubitemid 30497785)
24. Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin. Jardim AC, Yamasaki LH, de Queiroz AT, Bittar C, Pinho JR, Carareto CM, Rahal P, Mello IM, Infect Genet Evol 2009 9 89 698
25. Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response. Bittar C, Jardim AC, Yamasaki LH, de Queiroz AT, Carareto CM, Pinho JR, de Carvalho-Mello IM, Rahal P, BMC Infect Dis 2010 10 36 10.1186/1471-2334-10-36 20178583
26. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH, J Hepatol 2008 49 899 907 10.1016/j.jhep.2008.06.030 18842320
27. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment. Kang SM, Won SJ, Lee GH, Lim YS, Hwang SB, FEBS Lett 2010 584 4069 4076 10.1016/j.febslet.2010.08.032 20804757
28. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha. Scheel TK, Gottwein JM, Mikkelsen LS, Jensen TB, Bukh J, Gastroenterology 2011 140 1032 1042 10.1053/j.gastro.2010.11.036 21111742
29. Protein binding specificity versus promiscuity. Schreiber G, Keating AE, Curr Opin Struct Biol 2011 21 50 61 10.1016/j.sbi.2010.10.002 21071205
30. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. Taylor ME, Drickamer K, J Biol Chem 1993 268 399 404 8416946 (Pubitemid 23021335)
31. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Petrescu AJ, Milac AL, Petrescu SM, Dwek RA, Wormald MR, Glycobiology 2004 14 103 114 14514716 (Pubitemid 38263095)
32. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. Graff J, Zhou YH, Torian U, Nguyen H, St Claire M, Yu C, Purcell RH, Emerson SU, J Virol 2008 82 1185 1194 10.1128/JVI.01219-07 18032496
33. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Helenius A, Mol Biol Cell 1994 5 253 265 8049518 (Pubitemid 24116952)
34. Glycosylation in the nucleus and cytoplasm. Hart GW, Haltiwanger RS, Holt GD, Kelly WG, Annu Rev Biochem 1989 58 841 874 10.1146/annurev.bi.58.070189. 004205 2673024 (Pubitemid 19172989)
35. An intrinsic membrane glycoprotein with cytosolically oriented n-linked sugars. Pedemonte CH, Sachs G, Kaplan JH, Proc Natl Acad Sci USA 1990 87 9789 9793 10.1073/pnas.87.24.9789 2175915 (Pubitemid 120016529)
36. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. Kreppel LK, Blomberg MA, Hart GW, J Biol Chem 1997 272 9308 9315 10.1074/jbc.272.14.9308 9083067 (Pubitemid 27154943)
37. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Hart GW, Annu Rev Biochem 1997 66 315 335 10.1146/annurev.biochem.66.1.315 9242909 (Pubitemid 27274659)
38. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, Date T, Matsuura Y, Miyamura T, Wakita T, Suzuki T, J Virol 2008 82 7964 7976 10.1128/JVI.00826-08 18524832
39. Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Huang Y, Staschke K, De Francesco R, Tan SL, Virology 2007 364 1 9 10.1016/j.virol.2007.01.042 17400273 (Pubitemid 46829271)
40. Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. Tellinghuisen TL, Foss KL, Treadaway JC, Rice CM, J Virol 2008 82 1073 1083 10.1128/JVI.00328-07 18032500
41. NS5A phosphorylation and hyperphosphorylation. Neddermann P, Methods Mol Biol 2009 510 95 110 10.1007/978-1-59745-394-3-8 19009256
42. Protein N-myristoylation. Gordon JI, Duronio RJ, Rudnick DA, Adams SP, Gokel GW, J Biol Chem 1991 266 8647 8650 2026581 (Pubitemid 21906558)
43. The biology and enzymology of protein N-myristoylation. Farazi TA, Waksman G, Gordon JI, J Biol Chem 2001 276 39501 39504 10.1074/jbc.R100042200 11527981
44. Arg-Gly-Asp: a versatile cell recognition signal. Ruoslahti E, Pierschbacher MD, Cell 1986 44 517 518 10.1016/0092-8674(86)90259-X 2418980
45. The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin alpha5beta1. Rovere C, Luis J, Lissitzky JC, Basak A, Marvaldi J, Chretien M, Seidah NG, J Biol Chem 1999 274 12461 12467 10.1074/jbc.274.18.12461 10212221 (Pubitemid 29215478)
46. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Oba M, Aoyagi K, Miyata K, Matsumoto Y, Itaka K, Nishiyama N, Yamasaki Y, Koyama H, Kataoka K, Mol Pharm 2008 5 1080 1092 10.1021/mp800070s 19434856
47. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R, Gene 1996 182 203 211 10.1016/S0378-1119(96)00555-0 8982089 (Pubitemid 27007186)
48. Subcellular localization of hepatitis C viral proteins in mammalian cells. Kim JE, Song WK, Chung KM, Back SH, Jang SK, Arch Virol 1999 144 329 343 10.1007/s007050050507 10470257 (Pubitemid 29100904)
49. Nuclear localization and intramolecular cleavage of N-terminally deleted NS5A protein of hepatitis C virus. Song J, Nagano-Fujii M, Wang F, Florese R, Fujita T, Ishido S, Hotta H, Virus Res 2000 69 109 117 10.1016/S0168-1702(00) 00206-9 11018280
50. Cleavage of the hepatitis C virus NS5A protein by caspase-3 in the interferon sensitivity-determining region in a sequence-dependent manner. Hidajat R, Nagano-Fujii M, Deng L, Hotta H, Kobe J Med Sci 2004 50 153 166 16049355 (Pubitemid 41283768)
51. The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. Kalamvoki M, Georgopoulou U, Mavromara P, J Biol Chem 2006 281 13449 13462 10.1074/jbc.M601124200 16517592 (Pubitemid 43855257)
52. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Tanimoto A, Ide Y, Arima N, Sasaguri Y, Padmanabhan R, Biochem Biophys Res Commun 1997 236 360 364 10.1006/bbrc.1997.6967 9240441 (Pubitemid 27373300)
53. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Fukuma T, Enomoto N, Marumo F, Sato C, Hepatology 1998 28 1147 1153 10.1002/hep.510280433 9755255 (Pubitemid 28450279)
54. Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication. Sauter D, Himmelsbach K, Kriegs M, Carvajal Yepes M, Hildt E, J Hepatol 2009 50 861 871 19307038
55. Routine libraries for pattern recognition in quasispecies. Marucci EA, Zafalon GF, Jardim AC, Yamasaki LH, Bittar C, Rahal P, Machado JM, Genet Mol Res 2008 7 970 981 10.4238/vol7-3X-Meeting013 18949714
56. Improved prediction of protein secondary structure by use of sequence profiles and neural networks. Rost B, Sander C, Proc Natl Acad Sci USA 1993 90 7558 7562 10.1073/pnas.90.16.7558 8356056 (Pubitemid 23249989)
57. The predictprotein server. Rost B, Yachdav G, Liu J, Nucleic Acids Res 2004 32 321 W326 10.1093/nar/gkh377 15215403 (Pubitemid 39004075)
58. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Jones DT, Bioinformatics 2007 23 538 544 10.1093/bioinformatics/btl677 17237066 (Pubitemid 46522586)
59. The PROSITE database, its status in 1997. Bairoch A, Bucher P, Hofmann K, Nucleic Acids Res 1997 25 217 221 10.1093/nar/25.1.217 9016539 (Pubitemid 27303182)
60. Prediction of human protein function from post-translational modifications and localization features. Jensen LJ, Gupta R, Blom N, Devos D, Tamames J, Kesmir C, Nielsen H, Staerfeldt HH, Rapacki K, Workman C, et al. J Mol Biol 2002 319 1257 1265 10.1016/S0022-2836(02)00379-0 12079362 (Pubitemid 34729433)
61. Functionality of system components: conservation of protein function in protein feature space. Jensen LJ, Ussery DW, Brunak S, Genome Res 2003 13 2444 2449 10.1101/gr.1190803 14559779 (Pubitemid 37428268)
62. Java Applets for Power and Sample Size [Computer software]. Lenth RV, Java Applets for Power and Sample Size 2006 9 http://www.stat.uiowa.edu/ ∼rlenth/Power/